Sara Nunnery, an oncologist at Tennessee Oncology, discusses evolving HER2-positive treatment paradigms with McCann.
1 report, 1 independent
Updated Wed 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sara Nunnery, an oncologist at Tennessee Oncology, discusses evolving HER2-positive treatment paradigms with McCann.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sara Nunnery
medical researcher
Nothing else this week.
-
McCann
advertising agency
Nothing else this week.